BioProcessors Leases Space in Woburn
BioProcessors Corp., a dynamic new company that has created a cell-based platform to accelerate drug development and enable cell based screening, opened its east coast headquarters at 35-C Cabot Road, Woburn with Cummings Properties. Backed by lending venture capital firm Oxford BioScience Partners, BioProcessors reportedly leased 10,347 square feet. According to company officials, BioProcessors' focus is to expedite the discovery and development of therapeutic drugs. Andrey Zarur, CEO explained, "We use a unique micro fabricated platform to grow cells on microchips." The cell-based micro devices create faster pre-clinical testing and automated biological assay applications. The manufacturer and assembly of the platform and biologicals integration will be performed in Woburn, while BioProcessors' micro fabrication operations will remain in the San Francisco Bay Area. BioProcessors is an emerging company competing for market…